21 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33925146 | The Neuroprotective Effects of GPR4 Inhibition through the Attenuation of Caspase Mediated Apoptotic Cell Death in an MPTP Induced Mouse Model of Parkinson's Disease. | 2021 Apr 28 | 1 |
2 | 32926778 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Induced Parkinson's Disease in Mouse: Potential Association between Neurotransmitter Disturbance and Gut Microbiota Dysbiosis. | 2020 Oct 21 | 2 |
3 | 31690718 | Ablation of RIP3 protects from dopaminergic neurodegeneration in experimental Parkinson's disease. | 2019 Nov 5 | 1 |
4 | 29264673 | Neuroprotective effects of the gliopeptide ODN in an in vivo model of Parkinson's disease. | 2018 Jun | 1 |
5 | 29588573 | Vitexin protects dopaminergic neurons in MPTP-induced Parkinson's disease through PI3K/Akt signaling pathway. | 2018 | 1 |
6 | 28527958 | Treadmill exercise produces neuroprotective effects in a murine model of Parkinson's disease by regulating the TLR2/MyD88/NF-κB signaling pathway. | 2017 Jul 25 | 1 |
7 | 25730317 | Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress. | 2016 Jul | 1 |
8 | 26477638 | Protective effects of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside in the MPTP-induced mouse model of Parkinson's disease: Involvement of reactive oxygen species-mediated JNK, P38 and mitochondrial pathways. | 2015 Nov 15 | 1 |
9 | 24795109 | The role of nitric oxide on visual-evoked potentials in MPTP-induced Parkinsonism in mice. | 2014 Jun | 1 |
10 | 23184853 | Neuroprotective effects of umbelliferone and esculetin in a mouse model of Parkinson's disease. | 2013 Mar | 1 |
11 | 23933227 | Nicotine-encapsulated poly(lactic-co-glycolic) acid nanoparticles improve neuroprotective efficacy against MPTP-induced parkinsonism. | 2013 Dec | 1 |
12 | 22178176 | Dangguijakyak-san protects dopamine neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity under postmenopausal conditions. | 2012 Feb 15 | 1 |
13 | 21291942 | Targeting oxidative stress, mitochondrial dysfunction and neuroinflammatory signaling by selective cyclooxygenase (COX)-2 inhibitors mitigates MPTP-induced neurotoxicity in mice. | 2011 Jun 1 | 1 |
14 | 21562748 | The TrkB-positive dopaminergic neurons are less sensitive to MPTP insult in the substantia nigra of adult C57/BL mice. | 2011 Oct | 1 |
15 | 20937256 | Gene disruption of caspase-3 prevents MPTP-induced Parkinson's disease in mice. | 2010 Nov 12 | 7 |
16 | 19861252 | [P38MAPK pathway regulates COX-2 and caspase-3 expression in a mouse model of Parkinson disease]. | 2009 Oct | 1 |
17 | 18577498 | Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra. | 2008 Aug | 1 |
18 | 16957581 | Evidence of apoptosis in the subventricular zone and rostral migratory stream in the MPTP mouse model of Parkinson disease. | 2006 Sep | 1 |
19 | 12579817 | [Possible mechanisms of the protective effect of ginsenoside Rg1 on apoptosis in substantia nigra neurons]. | 2002 Apr | 1 |
20 | 11295768 | Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice. | 2001 Mar | 3 |
21 | 11739563 | Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease. | 2001 Dec 15 | 2 |